PROGNOSIS, DIALYSIS AND TRANSPLANTATION IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY: EVIDENCE FROM REAL-WORLD DATA

WCN23-0406
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Nephrotic Syndrome
 
 
 
 
PROGNOSIS, DIALYSIS AND TRANSPLANTATION IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY: EVIDENCE FROM REAL-WORLD DATA
Roccatello, D.(1);Kroes, M.(2)*;Smeets, S.(3);George, A.T.(4);Prieto, L.(3);De Courcy, J.(5);Garratt-Wheeldon, J.(5);Yao, L.(6);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)University Of Turin, Nephrology, Turin, Italy;(2)Novartis Pharma Ag, Value Access And Commercial Development, Basel, Switzerland;(3)Novartis Pharma Ag, Global Medical Affairs, Basel, Switzerland;(4)Novartis Healthcare Pvt. Ltd., Value And Access, Hyderabad, India;(5)Adelphi Real World, Real World, England, United Kingdom;(6)The First Hospital Of China Medical University, Nephrology, Shenyang, China;
https://storage.unitedwebnetwork.com/files/1041/2f8ab2e209c5a9618ce9b21518b999ee.pdf
 
if any